In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

View Content for:
Display:
  •          
Help with display options.
Results 1-22 of 22 for your search:
Drug:  gamma-secretase/Notch signalling pathway inhibitor RO4929097
Find trials that include:  Any drugs shown
Trial Status:  Closed
Start Over
        Show
1.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2010-02181, 8539, MCC-8539, CDR0000675612, N01CM00100, NCT01149356
2.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2011-02509, ABTC-1002, U01CA137443, NCT01189240
3.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2011-02524, 8491, U01CA069856, N01CM62206, CDR0000684220, MSKCC-10085, 10-085, NCT01196416
4.

Phase: Phase II
Type: Treatment
Status: Temporarily closed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: NP22383, 2008-006384-37, NCT01070927
5.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2011-02040, S0933, SWOG-S0933, CDR0000671815, U10CA032102, NCT01120275
6.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-02845, MCC 16221, N01CM62208, N01CM17107, N01CM17102, NCT01116687
7.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-03068, PHL-077, N01CM00032, NCT01141569
8.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000682105, PMH-PHL-079, PHL-079, 8635, NCT01175343
9.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2011-02527, CINJ-081001, CDR0000684276, 081001, 8576, NCT01200810
10.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2011-02537, 10-0273, U01CA070095, R21CA155259, UCHSC-10-0273, 8490, NCT01232829
11.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2011-02571, 10-191, N01CA69856, CDR0000692198, MSKCC-10191, 8467, NCT01270438
12.

Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: NO21321, NCT00532090
13.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2011-01550, PJC-003, CDR0000666959, PMH-PJC-003, U01CA132123, 8501, NCT01096355
14.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: Over 18
Sponsor: NCI
Protocol IDs: NCI-2011-01410, 09-177, U01CA069856, MSKCC-09177, 8556, NCT01119599
15.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2011-01428, PJC-004, CDR0000673867, U01CA132123, CAN-OCI-PJC-004, 8503, NCT01131234
16.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2011-01433, PHL-078, CDR0000674950, U01CA132123, PMH-PHL-078, 8575, NCT01145456
17.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-02918, CO09907, CDR0000680610, U01CA132123, U01CA062491, WCCC-CO09907, 8515, NCT01158274
18.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2011-02487, 09-080, CDR0000683397, UPCI-09-080, 8554, NCT01208441
19.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2011-02523, 10-089-A, N01CM62201, CDR0000683470, UCCRC-10-089-A, 8522, NCT01192763
20.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2011-02529, PJC-005, 8500, CDR0000684714, U01CA132123, PMH-PJC-005, NCT01198184
21.

Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2010-01975, 2009-0769, CDR0000684271, MDA-2009-0769, 8508, NCT01193881
22.

Phase: No phase specified
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2012-02916, CO09908, U01CA062491, CDR0000685426, WCCC-CO-09908, 8516, NCT01218620
New Search